Fate Therapeutics Inc (FATE)
4.06
-0.04
(-0.98%)
USD |
NASDAQ |
May 03, 16:00
4.06
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Total Return Level: 4.06 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 4.06 |
May 02, 2024 | 4.10 |
May 01, 2024 | 4.09 |
April 30, 2024 | 3.95 |
April 29, 2024 | 4.04 |
April 26, 2024 | 3.80 |
April 25, 2024 | 3.87 |
April 24, 2024 | 4.30 |
April 23, 2024 | 4.54 |
April 22, 2024 | 4.78 |
April 19, 2024 | 4.79 |
April 18, 2024 | 5.04 |
April 17, 2024 | 5.27 |
April 16, 2024 | 5.38 |
April 15, 2024 | 5.64 |
April 12, 2024 | 5.77 |
April 11, 2024 | 5.95 |
April 10, 2024 | 6.27 |
April 09, 2024 | 6.76 |
April 08, 2024 | 6.71 |
April 05, 2024 | 6.92 |
April 04, 2024 | 6.97 |
April 03, 2024 | 7.01 |
April 02, 2024 | 6.80 |
April 01, 2024 | 7.08 |
Date | Value |
---|---|
March 28, 2024 | 7.34 |
March 27, 2024 | 7.34 |
March 26, 2024 | 6.86 |
March 25, 2024 | 6.87 |
March 22, 2024 | 6.61 |
March 21, 2024 | 7.43 |
March 20, 2024 | 7.43 |
March 19, 2024 | 7.00 |
March 18, 2024 | 7.04 |
March 15, 2024 | 7.49 |
March 14, 2024 | 7.23 |
March 13, 2024 | 7.64 |
March 12, 2024 | 7.66 |
March 11, 2024 | 7.89 |
March 08, 2024 | 8.12 |
March 07, 2024 | 8.35 |
March 06, 2024 | 7.98 |
March 05, 2024 | 6.93 |
March 04, 2024 | 7.08 |
March 01, 2024 | 7.74 |
February 29, 2024 | 7.09 |
February 28, 2024 | 7.14 |
February 27, 2024 | 7.46 |
February 26, 2024 | 6.95 |
February 23, 2024 | 6.96 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
32.50
Average
24.18
Median
Apr 07 2020
Total Return Level Benchmarks
Amicus Therapeutics Inc | 10.40 |
Sarepta Therapeutics Inc | 133.66 |
ADMA Biologics Inc | 6.81 |
Ocular Therapeutix Inc | 6.17 |
Viking Therapeutics Inc | 76.97 |